Insights Into Chronic Lymphocytic Leukemia (CLL) 2024
Perspectives of community physicians on the treatment of CLL
Select Report
Florida – February 10, 2024
Faculty Chair
Amitkumar Mehta, MD
University of Alabama, Birmingham, AL, USA
More Information
- Tampa, FL
- Florida
REPORT SNAPSHOT
- A moderated roundtable discussion focusing on the treatment of CLL
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained: acalabrutinib, ibrutinib, zanubrutinib, obinutuzumab, rituximab, venetoclax, duvelisib, idelalisib, FCR, and BR
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 10–15 medical oncologists representative of each region
